Advertisement
Advertisement

PEN

PEN logo

Penumbra, Inc.

324.37
USD
Sponsored
+0.62
+0.19%
Aug 25, 15:59 UTC -4
Closed
exchange

Pre-Market

323.07

-1.30
-0.40%

PEN Earnings Reports

Positive Surprise Ratio

PEN beat 35 of 43 last estimates.

81%

Next Report

Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$406.08M
/
$1.31
Implied change from Q2 26 (Revenue/ EPS)
+4.11%
/
+48.86%
Implied change from Q3 25 (Revenue/ EPS)
+14.49%
/
+35.05%

Penumbra, Inc. earnings per share and revenue

On Jul 30, 2026, PEN reported earnings of 0.88 USD per share (EPS) for Q2 26, missing the estimate of 1.19 USD, resulting in a -26.59% surprise. Revenue reached 390.05 million, compared to an expected 392.90 million, with a -0.73% difference. The market reacted with a +0.43% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 1.31 USD, with revenue projected to reach 406.08 million USD, implying an increase of 48.86% EPS, and increase of 4.11% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Electromed, Inc.
Report Date
Aug 25, 2026 For Q4 26
Estimate
$0.31
Actual
$0.39
Surprise
+23.34%
logo
LENSAR, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.16
Actual
$0.10
Surprise
+159.42%
logo
Sensus Healthcare, Inc
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.12
Actual
-$0.18
Surprise
-41.18%
logo
QT Imaging Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.22
Actual
-$0.19
Surprise
+15.06%
logo
Accuray Incorporated
Report Date
Aug 19, 2026 For Q4 26
Estimate
-$0.10
Actual
-$0.02
Surprise
+80.39%
logo
American Shared Hospital Services
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.07
Surprise
-246.53%
logo
ENvue Medical, Inc. Common Stock
Report Date
Aug 17, 2026 For Q2 26
Estimate
-
Actual
-$1.98
Surprise
-
logo
Nuwellis, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.69
Actual
-$26.64
Surprise
-3,740.83%
logo
Tenon Medical, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$8.56
Actual
-$12.35
Surprise
-44.14%
FAQ
For Q2 2026, Penumbra, Inc. reported EPS of $0.88, missing estimates by -26.59%, and revenue of $390.05M, -0.73% below expectations.
The stock price moved up 0.43%, changed from $319.83 before the earnings release to $321.19 the day after.
The next earning report is scheduled for Nov 03, 2026.
Based on -- analysts, Penumbra, Inc. is expected to report EPS of $1.31 and revenue of $406.08M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement